Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. IRON
IRON logo

IRON

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IRON News

Chronic Kidney Disease Market Growth Drivers

Mar 03 2026Newsfilter

Pomerantz LLP Investigates Claims on Behalf of Disc Medicine Investors

Mar 03 2026Globenewswire

Disc Medicine CFO Sells 11,156 Shares Amid FDA Rejection

Mar 01 2026Fool

Disc Medicine CFO Sells Shares, Reduces Holdings

Mar 01 2026NASDAQ.COM

Disc Medicine Initiates Restructuring Plan with 20% Layoffs

Feb 27 2026seekingalpha

Disc Medicine Reports FY Loss and Cash Position Improvement

Feb 26 2026seekingalpha

BVF Acquires New Position in Disc Medicine

Feb 25 2026Fool

BVF Hedge Fund Acquires 650,000 Shares of Disc Medicine

Feb 25 2026NASDAQ.COM

Great Point Partners Acquires $19.85 Million Stake in Disc Medicine

Feb 25 2026Fool

Pomerantz LLP Investigates Claims for Disc Medicine Investors

Feb 24 2026Globenewswire

Pomerantz LLP Investigates Claims for Disc Medicine Investors

Feb 20 2026PRnewswire

Disc Medicine Shares Drop 22% Due to FDA Regulatory Setback

Feb 17 2026Benzinga

Disc Medicine Shares Plunge 22% After FDA Complete Response Letter

Feb 13 2026seekingalpha

Disc Medicine's Drug Approval Denied, Shares Plunge 21%

Feb 13 2026stocktwits

FDA Responds to Bitopertin Application with Complete Response Letter

Feb 13 2026Newsfilter

Pomerantz LLP Investigates Securities Fraud Claims Against Disc Medicine

Jan 27 2026Globenewswire